Flavien Susanne

Flavien Susanne is an accomplished professional in the field of chemical development and manufacturing, currently serving as VP and head of chemical development and clinical manufacturing at AstraZeneca from September 2023 to April 2025. Previously, Flavien held significant roles at Sanofi as CMC Site Head and Head of Drug Substance Process Development & Clinical Manufacturing, and also as Head of Chemical Development and Engineering. Prior experience includes leading product development at SiSaf Ltd and driving global product development and supply continuous processing at GSK. Flavien began a career at Novartis as a Continuous Processing Engineer Team Leader, focusing on the implementation of continuous technologies. Educational qualifications include an Advanced Chemical Engineering degree and a DEA in Organic Chemistry from institutions in Normandy, France.